EE357 Cost per Responder Analysis Comparing Adagrasib and Sotorasib in Patients With KRAS G12C-Mutated Previously Treated Non-Small Cell Lung Cancer (NSCLC)
Abstract
Authors
A. Berardi M. Laurie C. Theriou I. Orsini W. Bouwmeester S. Gao B. Korytowsky